Abstract: A low voltage driver for a higher voltage LCD includes a plurality of LCD drive bias voltage input-terminals; an LCD drive voltage output terminal; an input transistor switching circuit having at least one switch for each LCD drive bias voltage for selecting one of the bias voltages; an output transistor switching circuit, responsive to the input transistor switching circuit, for applying the selected one of the bias voltages to the LCD drive voltage output terminal, the transistors of the switching circuits having a predetermined breakdown voltage; a level shifter for providing switching voltages counterpart to the plurality of bias voltages; a logic circuit for enabling the first transistor switching circuit to select a one of the bias voltages and applying a set of counterpart switching voltages to the input and output transistor switching circuits for connecting the selected one of the bias voltages to the output terminal and applying a set of switching voltages to the input and output switching circuits

Abstract: The present invention is drawn to adhesive peel-forming formulations for dermal delivery of a drug. The formulation can include a drug, a solvent vehicle, and a peel-forming agent. The solvent vehicle can include a volatile solvent system having one or more volatile solvent, and a non-volatile solvent system having one or more non-volatile solvent, wherein the non-volatile solvent system has a solubility for the drug that is within a window of operable solubility for the drug such that the drug can be delivered at therapeutically effective rates over a sustained period of time. The formulation can have a viscosity suitable for application to a skin surface prior to evaporation of the volatile solvents system. When applied to the skin, the formulation can form a solidified peelable layer after at least a portion of the volatile solvent system is evaporated.

Abstract: The present invention is drawn to systems and methods for reducing unintended use of an active ingredient, such as residual active ingredients present in spent dermal patches and peels. The system can include a dermal patch including an active ingredient and a destructive agent configured to chemically react with the active ingredient. The destructive agent can be present in a container or an absorber. In one embodiment, the absorber can be used within the container. The container can be configured to receive the dermal patch such that the active ingredient contacts the destructive agent within the container. The absorber can be configured to contact the dermal patch such that the active ingredient contacts the destructive agent of the absorber. Additionally, systems and methods for impeding the unintended use of an active ingredient, such as those present in dermal patches or peels, are also provided.